Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis.

Rabin RA, Zakzanis KK, George TP.

Schizophr Res. 2011 May;128(1-3):111-6. doi: 10.1016/j.schres.2011.02.017. Epub 2011 Mar 21. Review.

PMID:
21420282
2.

Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder.

Ringen PA, Melle I, Berg AO, Agartz I, Spigset O, Simonsen C, Sundet K, Andreassen OA.

Schizophr Res. 2013 Jan;143(1):84-9. doi: 10.1016/j.schres.2012.10.021. Epub 2012 Nov 22.

PMID:
23178107
3.

Neurocognitive functioning and cannabis use in schizophrenia.

Segev A, Lev-Ran S.

Curr Pharm Des. 2012;18(32):4999-5007. Review.

PMID:
22716156
4.

Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings.

Sánchez-Torres AM, Basterra V, Rosa A, Fañanás L, Zarzuela A, Ibáñez B, Peralta V, Cuesta MJ.

Eur Arch Psychiatry Clin Neurosci. 2013 Dec;263(8):643-53. doi: 10.1007/s00406-013-0404-5. Epub 2013 Apr 12.

PMID:
23580110
5.

Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects.

Rentzsch J, Buntebart E, Stadelmeier A, Gallinat J, Jockers-Scherübl MC.

Schizophr Res. 2011 Aug;130(1-3):222-7. doi: 10.1016/j.schres.2011.05.011. Epub 2011 May 31.

PMID:
21624823
6.

Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.

Mata I, Rodríguez-Sánchez JM, Pelayo-Terán JM, Pérez-Iglesias R, González-Blanch C, Ramírez-Bonilla M, Martínez-García O, Vázquez-Barquero JL, Crespo-Facorro B.

Psychol Med. 2008 Sep;38(9):1257-66. Epub 2007 Nov 16.

PMID:
18005495
7.

Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.

Ringen PA, Vaskinn A, Sundet K, Engh JA, Jónsdóttir H, Simonsen C, Friis S, Opjordsmoen S, Melle I, Andreassen OA.

Psychol Med. 2010 Aug;40(8):1337-47. doi: 10.1017/S0033291709991620. Epub 2009 Nov 6.

PMID:
19891810
8.

The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use.

Coulston CM, Perdices M, Tennant CC.

Schizophr Res. 2007 Nov;96(1-3):169-84. Epub 2007 Sep 10.

PMID:
17826035
9.

The role of cannabis in cognitive functioning of patients with schizophrenia.

Schnell T, Koethe D, Daumann J, Gouzoulis-Mayfrank E.

Psychopharmacology (Berl). 2009 Jul;205(1):45-52. doi: 10.1007/s00213-009-1512-9. Epub 2009 Mar 27.

PMID:
19326102
10.

Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia.

Scholes KE, Martin-Iverson MT.

Psychol Med. 2010 Oct;40(10):1635-46. doi: 10.1017/S0033291709992078. Epub 2009 Dec 17.

PMID:
20018124
11.

Neurocognitive functions of heavy cannabis using schizophrenia patients.

Lev-Ran S, Segev A, Braw Y, Levkovitz Y.

Eur Psychiatry. 2012 Jul;27(5):365-8. doi: 10.1016/j.eurpsy.2011.04.010. Epub 2011 Jun 24.

PMID:
21704501
12.

Cannabis use and neurocognitive functioning in a non-clinical sample of users.

Thames AD, Arbid N, Sayegh P.

Addict Behav. 2014 May;39(5):994-9. doi: 10.1016/j.addbeh.2014.01.019. Epub 2014 Feb 6.

13.

The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.

Yücel M, Bora E, Lubman DI, Solowij N, Brewer WJ, Cotton SM, Conus P, Takagi MJ, Fornito A, Wood SJ, McGorry PD, Pantelis C.

Schizophr Bull. 2012 Mar;38(2):316-30. doi: 10.1093/schbul/sbq079. Epub 2010 Jul 25.

14.

Neurocognitive moderation of associations between cannabis use and psychoneuroticism.

Huijbregts SC, Griffith-Lendering MF, Vollebergh WA, Swaab H.

J Clin Exp Neuropsychol. 2014;36(8):794-805. doi: 10.1080/13803395.2014.943694. Epub 2014 Aug 13.

PMID:
25116129
15.

Cannabis use disorders in schizophrenia: effects on cognition and symptoms.

DeRosse P, Kaplan A, Burdick KE, Lencz T, Malhotra AK.

Schizophr Res. 2010 Jul;120(1-3):95-100. doi: 10.1016/j.schres.2010.04.007. Epub 2010 May 18.

16.
17.

The assessment of neuropsychological functioning in schizophrenia.

Reichenberg A.

Dialogues Clin Neurosci. 2010;12(3):383-92. Review.

18.

Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.

Meijer JH, Dekker N, Koeter MW, Quee PJ, van Beveren NJ, Meijer CJ; Genetic Risk and Outcome of Psychosis (GROUP) Investigators.

Psychol Med. 2012 Apr;42(4):705-16. doi: 10.1017/S0033291711001656. Epub 2011 Sep 7.

PMID:
21899795
19.

Effects of cannabis use status on cognitive function, in males with schizophrenia.

Rabin RA, Zakzanis KK, Daskalakis ZJ, George TP.

Psychiatry Res. 2013 Apr 30;206(2-3):158-65. doi: 10.1016/j.psychres.2012.11.019. Epub 2012 Dec 13.

PMID:
23246245
20.

[Cannabis and schizophrenia: demographic and clinical correlates].

Dervaux A, Laqueille X, Bourdel MC, Leborgne MH, Olié JP, Lôo H, Krebs MO.

Encephale. 2003 Jan-Feb;29(1):11-7. French.

PMID:
12640322
Items per page

Supplemental Content

Write to the Help Desk